title: Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.
abstract: Pathogen-specific antibody plays an important role in protection against pneumococcal carriage and infections. However, neonates and infants exhibit impaired innate and adaptive immune responses, which result in their high susceptibility to pneumococci. To protect neonates and infants against pneumococcal infection it is important to elicit specific protective immune responses at very young ages. In this study, we investigated the protective immunity against pneumococcal carriage, pneumonia, and sepsis induced by maternal immunization with pneumococcal surface protein A (PspA). Mother mice were intranasally immunized with recombinant PspA (rPspA) and cholera toxin B subunit (CTB) prior to being mated. Anti-PspA specific IgG, predominantly IgG1, was present at a high level in the serum and milk of immunized mothers and in the sera of their pups. The pneumococcal densities in washed nasal tissues and in lung homogenate were significantly reduced in pups delivered from and/or breast-fed by PspA-immunized mothers. Survival after fatal systemic infections with various types of pneumococci was significantly extended in the pups, which had received anti-PspA antibody via the placenta or through their milk. The current findings strongly suggest that maternal immunization with PspA is an attractive strategy against pneumococcal infections during early childhood.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Wakayama Medical University, Wakayama-city, Wakayama, Japan.
authors.forename: Masamitsu
authors.initials: M
authors.lastname: Kono
authors.forename: Muneki
authors.initials: M
authors.lastname: Hotomi
authors.forename: Susan K
authors.initials: SK
authors.lastname: Hollingshead
authors.forename: David E
authors.initials: DE
authors.lastname: Briles
authors.forename: Noboru
authors.initials: N
authors.lastname: Yamanaka
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D000831:Animals, Newborn; D000907:Antibodies, Bacterial / Q000097:blood; D001426:Bacterial Proteins / Q000008:administration & dosage* / Q000276:immunology; D002772:Cholera Toxin / Q000276:immunology*; D005260:Female; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D011008:Pneumococcal Infections / Q000276:immunology* / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000276:immunology*; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D011994:Recombinant Proteins; C051592:pneumococcal surface protein A; D002772:Cholera Toxin
references.citation: Pediatr Infect Dis J. 2000 Feb;19(2):134-8
references.pmid: 10694000
references.citation: Vaccine. 2000 Feb 25;18(16):1707-11
references.pmid: 10689153
references.citation: J Infect Dis. 2007 Nov 1;196(9):1339-45
references.pmid: 17922398
references.citation: J Infect Dis. 2002 Apr 1;185(7):927-36
references.pmid: 11920317
references.citation: Clin Infect Dis. 2011 May;52(10):1241-7
references.pmid: 21507921
references.citation: Reg Immunol. 1992 Mar-Apr;4(2):54-62
references.pmid: 1503889
references.citation: Microb Drug Resist. 2008 Jun;14(2):101-7
references.pmid: 18491947
references.citation: Infect Immun. 2000 Oct;68(10):5889-900
references.pmid: 10992499
references.citation: Infect Immun. 2000 May;68(5):3028-33
references.pmid: 10769009
references.citation: Clin Vaccine Immunol. 2010 Mar;17(3):439-46
references.pmid: 20089795
references.citation: Infect Immun. 2000 Feb;68(2):796-800
references.pmid: 10639448
references.citation: J Immunol. 1995 Jun 15;154(12):6246-51
references.pmid: 7759862
references.citation: Pediatr Int. 2000 Aug;42(4):337-42
references.pmid: 10986861
references.citation: J Cell Biol. 1990 Nov;111(5 Pt 1):1867-76
references.pmid: 2146275
references.citation: Acta Otolaryngol. 1999;119(6):703-7
references.pmid: 10587005
references.citation: J Infect Dis. 2000 Dec;182(6):1694-701
references.pmid: 11069242
references.citation: Pediatr Infect Dis J. 2007 Sep;26(9):771-7
references.pmid: 17721369
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14363-7
references.pmid: 14610280
references.citation: Eur J Epidemiol. 2004;19(4):365-75
references.pmid: 15180107
references.citation: Clin Microbiol Rev. 1998 Oct;11(4):645-57
references.pmid: 9767061
references.citation: Microb Pathog. 2010 Jun;48(6):205-13
references.pmid: 20206678
references.citation: Infect Immun. 2007 Dec;75(12):5930-8
references.pmid: 17923518
references.citation: J Pediatr. 1993 Feb;122(2):212-8
references.pmid: 8429433
references.citation: Nat Med. 2005 Apr;11(4 Suppl):S45-53
references.pmid: 15812489
references.citation: Vaccine. 2009 May 21;27(24):3181-8
references.pmid: 19446189
references.citation: Lancet. 2009 Sep 12;374(9693):893-902
references.pmid: 19748398
references.citation: J Clin Invest. 2006 Aug;116(8):2142-2151
references.pmid: 16841095
references.citation: J Immunol. 2009 Jun 1;182(11):7155-62
references.pmid: 19454712
references.citation: Eur J Immunol. 1985 Jul;15(7):733-8
references.pmid: 2988974
references.citation: J Infect Dis. 2007 Nov 1;196(9):1346-54
references.pmid: 17922399
references.citation: Nat Rev Immunol. 2006 Feb;6(2):148-58
references.pmid: 16491139
references.citation: Clin Diagn Lab Immunol. 1994 Nov;1(6):667-9
references.pmid: 8556518
references.citation: Vaccine. 1996 Jun;14(9):858-67
references.pmid: 8843627
references.citation: Nature. 2008 Sep 25;455(7212):542-6
references.pmid: 18818657
references.citation: J Infect Dis. 2007 Nov 1;196(9):1282-4
references.pmid: 17922390
references.citation: Infect Immun. 2002 Sep;70(9):5086-90
references.pmid: 12183557
references.citation: Clin Infect Dis. 1999 Feb;28(2):219-24
references.pmid: 10064230
references.citation: Vaccine. 2000 Mar 6;18(17):1743-54
references.pmid: 10699322
references.citation: Infect Immun. 2001 Nov;69(11):6718-24
references.pmid: 11598043
references.citation: J Clin Invest. 1999 Oct;104(7):903-11
references.pmid: 10510331
references.citation: J Infect Dis. 2000 May;181(5):1842-5
references.pmid: 10823798
references.citation: Vaccine. 2010 Nov 10;28(48):7634-43
references.pmid: 20883739
references.citation: Clin Vaccine Immunol. 2008 Mar;15(3):499-505
references.pmid: 18184825
references.citation: Infect Immun. 2005 Oct;73(10):6945-51
references.pmid: 16177374
references.citation: J Infect Dis. 1996 Dec;174(6):1271-8
references.pmid: 8940218
references.citation: J Immunol. 2010 Aug 1;185(3):1755-62
references.pmid: 20585031
references.citation: Vaccine. 2003 Jul 28;21(24):3365-9
references.pmid: 12850341
references.citation: Vaccine. 2003 Jul 28;21(24):3473-8
references.pmid: 12850363
references.citation: Vaccine. 2006 Jun 19;24(25):5294-9
references.pmid: 16697503
references.citation: N Engl J Med. 2003 May 1;348(18):1737-46
references.pmid: 12724479
references.citation: N Engl J Med. 2001 Oct 18;345(16):1177-83
references.pmid: 11642234
references.citation: J Infect Chemother. 2008 Dec;14(6):393-8
references.pmid: 19089550
references.citation: Clin Exp Immunol. 2004 Mar;135(3):474-7
references.pmid: 15008981
references.citation: J Exp Med. 2002 Aug 5;196(3):303-10
references.pmid: 12163559
references.citation: Clin Vaccine Immunol. 2009 May;16(5):636-45
references.pmid: 19279169
references.citation: Lancet. 2006 Mar 4;367(9512):740-8
references.pmid: 16517274
references.citation: Vaccine. 2003 Jul 28;21(24):3451-4
references.pmid: 12850358
references.citation: Nat Biotechnol. 2011 Feb;29(2):158-63
references.pmid: 21240266
references.citation: Infect Immun. 2009 Apr;77(4):1613-22
references.pmid: 19168741
references.citation: J Infect Dis. 1996 Feb;173(2):380-6
references.pmid: 8568299
references.citation: J Infect Dis. 2007 Nov 15;196(10):1528-36
references.pmid: 18008233
references.citation: JAMA. 2007 Apr 25;297(16):1784-92
references.pmid: 17456820
references.citation: N Engl J Med. 2008 Oct 9;359(15):1555-64
references.pmid: 18799552
references.citation: J Infect Dis. 1997 Apr;175(4):839-46
references.pmid: 9086139
references.citation: Curr Opin Infect Dis. 2006 Jun;19(3):271-6
references.pmid: 16645489
references.citation: Eur J Epidemiol. 2004;19(4):353-63
references.pmid: 15180106
references.citation: Clin Infect Dis. 2004 Oct 1;39(7):930-8
references.pmid: 15472842
references.citation: Immunology. 1997 Sep;92(1):69-74
references.pmid: 9370926
references.citation: J Infect Dis. 2000 Oct;182(4):1146-52
references.pmid: 10979911
references.citation: Microb Pathog. 2008 Mar;44(3):204-14
references.pmid: 18006268
references.citation: Pediatr Infect Dis J. 2004 Nov;23(11):1015-22
references.pmid: 15545856
references.citation: Expert Rev Vaccines. 2005 Dec;4(6):813-8
references.pmid: 16372877
references.citation: Biol Reprod. 2000 Dec;63(6):1817-24
references.pmid: 11090454
references.citation: Vaccine. 2009 Aug 21;27 Suppl 3:C22-4
references.pmid: 19545935
references.citation: Vaccine. 2001 Dec 12;20(5-6):826-37
references.pmid: 11738746